Rigaku Announce New President & COO
News Apr 07, 2015
Rigaku Corporation has announced that, as of April 1, 2015, Mr. Yoichi Yokomizo succeeded Mr. Wes Hardenburg to become President and Chief Operating Officer (COO) of Rigaku Americas Holding Company, Inc. (RAH).
Mr. Hikaru Shimura, Rigaku Corporation Chairman and CEO, said that this change was made "in order to better encourage growth throughout the Rigaku Group and to ensure that we are able to effectively pursue our mission of contributing to the enhancement of humanity through scientific and technological development … his presence will facilitate better communication and a stronger connection between the U.S.-based Rigaku businesses and Rigaku Corporation in Japan.”
Prior to this assignment, Mr. Yokomizo served as Executive VP and General Manager of Rigaku’s Global Sales and Marketing Group. Previous to joining Rigaku in 2012, Mr. Yokomizo amassed a wealth of experience in managing organizations with strong leadership as an “Innovation Leader.”
Former positions included being EVP/CIO for Lawson, Inc., President and CEO of i2 Technologies (Japan) and General Manager for IT strategy at Mitsubishi Corporation (Japan). Mr. Yokomizo has B.S. and M.S. degrees in mechanical engineering from Keio University and a M.B.A. degree from the Massachusetts Institute of Technology (MIT).
As of April 1, 2015, Mr. Wes Hardenburg resigned his position with Rigaku to pursue other interests. Mr. Hardenburg commented that “it was with great pleasure and an honor to work with the team members of Rigaku since December 1991 … I am looking forward to hearing about Rigaku achieving its goals and wishing a prosperous and exciting future for all.”
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Cellular Valve Structure Opens Up Potential Novel TherapiesNews
Biochemists have determined the detailed structure of a volume-regulated chloride channel. This cellular valve is activated in response to swelling to prevent the cell from bursting. The protein also plays an important role in the uptake of chemotherapeutics and the release of neurotransmitters after a stroke. The controlled regulation of its activity thus opens up a promising strategy for novel therapies.READ MORE
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018